GF/B33/EDP20
Approved by the Board on: 12 October 2015
Decision on the Secretariat’s Recommendation on Additional Funding from the 2014 Allocation
The Board:
- Approves the incremental funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of Section IV to GF/B33/ER14 (“Table 1”);
- Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
- Affirms the incremental funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component’s constituent grants, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.
Annex:
Azerbaijan (AZE-T-MOH), Bangladesh (BGD-H-NASP, BGD-H-SC, BGD-H-ICDDRB), Cape Verde (CPV-C-CCSSIDA), Comoros (COM-M-PNLP), Haiti (HTI-C-PSI), Lao (People's Democratic Republic) (LAO-H-GFMOH), Panama (PAN-C-UNDP), Sri Lanka (LKA-M-MOH), Zanzibar (QNB-C-MOH).
Regional grants: Abidjan-Lagos Corridor Organization (OCAL) (QPF-H-ALCO), African Network for the Care of Children Affected by HIV/AIDS (ANECCA) (QPA-H-ANECCA), ECSA-HC Uganda Supranational National Reference Laboratory (QPA-T-ECSA), Humanist Institute for Cooperation with Developing Countries, Southern Africa (HIVOS) (QPA-H-HIVOS), Removal of Legal Barriers (RLB) (QPA-H-UNDP).
Notes
A register of the Board's Funding Decisions is available here.